annb0t
Top 20
Incannex Healthcare Ltd. shares jumped 7% after the Australia-based cannabinoid and psychedelic compound medicine development company said it would pay $93.3 million to acquire APIRx Pharmaceutical USA LLC, a pharmaceutical medicinal cannabinoid product development company. Incannex said the acquisition of APIRx will provide a portfolio of "promising therapeutic candidates" targeted at treating pain, dementia, Parkinson's Disease, restless leg syndrome, gastrointestinal diseases, periodontitis,
>>> Read more: Incannex Healthcare rallies after airing plan to buy cannabis medicine company APIRx
>>> Read more: Incannex Healthcare rallies after airing plan to buy cannabis medicine company APIRx
